Clinical manifestations, therapy and outcome of pandemic influenza a (H1N1) 2009 in hospitalized patients;Kliničko ispoljavanje, terapija i ishod pandemijskog gripa a (H1N1) 2009 kod hospitalizovanih bolesnika

Vojnosanitetski Pregled

Volumn 68, Issue 3, 2011, Pages 248-256

  Mikić, Dragan ^a   Nožić, Darko ^a   Kojić, Miroslav ^a   Popović, Svetlana ^a   Hristović, Dejan ^a   Dimitrijević, Radmila Rajić ^a   Ćurčić, Petar ^a   Milanović, Milomir ^a   Glavatović, Rade ^a   Kuprešanin, Vesna Begović ^a   Veljović, Milić ^a   Djordjević, Dragan ^a   Kapulica, Nada Kuljić ^a   Čekanac, Radovan ^a   Stefanovič, Dara ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Disease progression; Disease transmission Infections; Drug therapy; H1N1 subtype; Influenza a virus; Mortality

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTRIAXONE; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ACUTE RESPIRATORY FAILURE; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL FEATURE; COUGHING; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; FEMALE; FEVER; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OBESITY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; MALE; PANDEMICS; SERBIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952733564     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1103248M     Document Type: Article

References (62)

1. Centers for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58(15): 400-2.
2. Update: swine influenza A (H1N1) infections-California and Texas, April 2009. MMWR Morb Mortal Wkly Rep 2009; 58(16): 435-7.
3. Centers for Disease Control and Prevention (CDC). Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009. MMWR Morb Mortal Wkly Rep 2009; 58(21): 585-9.
4. WHO. Pandemic (H1N1) 2009 - update 67. Geneva: World Health Organization; 2009.
5. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009;45(3): 169-73.
6. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360(25): 2605-15.
7. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009; 459(7249): 931-9.
8. Scalera NM, Mossad SB. The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus. Postgrad Med 2009; 121(5): 43-7.
9. Chang LY, Shih SR, Shao PL, Huang DT, Huang LM. Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J Formos Med Assoc 2009; 108(7): 526-32.
10. Wenzel RP, Edmond MB. Preparing for 2009 H1N1 Influenza. N Engl J Med 2009; 361(20): 1991-3.
11. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008; 453(7195): 615-9.
12. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325(5937): 197-201.
13. Patel M, Dennis A, Flutter C, Khan Z. Pandemic (H1N1) 2009 influenza. Br J Anaesth 2010; 104(2): 128-42.
14. Denholm JT, Gordon CL, Johnson PD, Hewagama SS, Stuart RL, Aboltins C, et al. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust 2010; 192(2): 84-6.
15. Belongia EA, Irving SA, Waring SC, Coleman LA, Meece JK, Vandermause M, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA 2010; 304(10): 1091-8.
16. Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep 2009; 58(19): 536-41.
17. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361(20): 1935-44.
18. Cui W, Zhao H, Lu X, Wen Y, Zhou Y, Deng B, et al. Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis 2010; 10: 145.
19. Lee EH, Wu C, Lee EU, Stoute A, Hanson H, Cook HA, et al. Fatalities associated with the 2009 H1N1 influenza A virus in New York city. Clin Infect Dis 2010; 50(11): 1498-504.
20. Jaber S, Conseil M, Coisel Y, Jung B, Chanques G. ARDS and influenza A (H1N1): patients' characteristics and management in intensive care unit. A literature review. Ann Fr Anesth Reanim 2010; 29(2): 117-25. (French)
21. Jain R, Goldman RD. Novel influenza A(H1N1): clinical presentation, diagnosis, and management. Pediatr Emerg Care 2009; 25(11): 791-6.
22. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302(17): 1880-7.
23. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302(17): 1872-9.
24. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009; 58(27): 749-52.
25. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 2009; 302(17): 1888-95.
26. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302(17): 1896-902.
27. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hay-den FG, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48(8): 1003-32.
28. Centers for Diseases Control. Interim guidance on antiviral recommendations for patients with novel influenza A (H1N1) virus infection and their close contacts. Atlanta, GA: US Department of Health and Human Services, CDC; 2009.
29. Hajjar LA, Schout D, Galas FR, Uip DE, Levin AS, Caiaffa Filho HH, et al. Guidelines on management of human infection with the novel virus influenza A (H1N1)-a report from the Hospital das Clínicas of the University of São Paulo. Clinics (Sao Paulo) 2009; 64(10): 1015-24.
30. Nicholson KG. Clinical features of influenza. Semin Respir Infect 1992; 7(1): 26-37.
31. Cox NJ, Subbarao K. Influenza. Lancet 1999; 354(9186): 1277-82.
32. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289(2): 179-86.
33. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292(11): 1333-40.
34. Human infection with pandemic A (H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009 - update. Wkly Epidemiol Rec 2009; 84(30): 305-8. (English, French)
35. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361(7): 680-9.
36. Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 195; 38(1 Part 2): 213-65.
37. Keren R, Zaoutis TE, Bridges CB, Herrera G, Watson BM, Wheeler AB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005; 294(17): 2188-94.
38. Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc 2002; 50(9): 1498-503.
39. Lapinsky SE. H1N1 novel influenza A in pregnant and immu-nocompromised patients. Crit Care Med 2010; 38(4 Suppl): e52-7.
40. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361(20): 1945-52.
41. Zimmer SM, Burke DS. Historical perspective - Emergence of influenza A (H1N1) viruses. N Engl J Med 2009; 361(3): 279-85.
42. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009; 361(7): 674-9.
43. Azziz-Baumgartner E, Smith N, González-Alvarez R, Daves S, Layton M, Linares N, et al. National pandemic influenza preparedness planning. Influenza Other Respi Viruses 2009; 3(4): 189-96.
44. Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007; 176(4): 463-8.
45. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374(9688): 451-8.
46. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148(11): 1094-102.
47. Harris JW. Influenza occurring in pregnant women. JAMA 1919; 72: 978-80.
48. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959; 78: 1172-5.
49. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374(9688): 451-8.
50. Dubar G, Launay O, Batteux F, Tsatsaris V, Goffinet F, Mignon A. Pregnancy and pandemic influenza A(H1N1) 2009. Current concepts for anaesthesia and critical care medicine. Ann Fr Anesth Reanim 2010; 29(2): 126-34. (French)
51. Hers JF, Masurel N, Mulder J. Bacteriology and histopathol-ogy of the respiratory tract and lungs in fatal Asian influenza. Lancet 1958; 2(7057): 1141-3.
52. Finelli L, Fiore A, Dhara R, Brammer L, Shay DK, Kamimoto L, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122(4): 805-11.
53. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198(7): 962-70.
54. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58(38): 1071-4.
55. Reddy D. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir. J Antimicrob Chemother 2010; 65(Suppl 2): ii35-40.
56. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009; 58(35): 969-72.
57. Rungrotmongkol T, Intharathep P, Malaisree M, Nunthaboot N, Kai-yawet N, Sompornpisut P, et al. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. Biochem Biophys Res Commun 2009; 385(3): 390-4.
58. Poland GA, Jacobson RM, Ovsyannikova IG. Influenza virus resistance to antiviral agents: a plea for rational use. Clin Infect Dis 2009; 48(9): 1254-6.
59. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009; 301(10): 1034-41.
60. Dutkowski R. Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. J Antimicrob Chemother 2010; 65 Suppl 2: ii11-ii24.
61. Smith JR, Ariano RE, Toovey S. The use of antiviral agents for the management of severe influenza. Crit Care Med 2010; 38(4 Suppl): e43-51.
62. Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ 2009; 181(1-2): 55-8.